Insider trade

Hims & Hers Health (HIMS): CEO reported a gift or transfer of 463K shares

Andrew Dudum, CEO at Hims & Hers Health, reported a gift / transfer of 463K shares.

463K
Shares
Traded
Aug 25, 2026
Filed
Aug 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 18, 2026InsiderCFO sold ~$1.94M of HIMS shares in the open market
  2. Jun 26, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  3. Jul 6, 2026InsiderCFO sold ~$261K of HIMS shares in the open market
  4. Jul 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.”
  5. Jul 17, 2026InsiderCFO sold ~$229K of HIMS shares in the open market
  6. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
  7. Aug 17, 2026InsiderCFO sold ~$262K of HIMS shares in the open market
  8. Aug 18, 2026InsiderDirector sold ~$467K of HIMS shares in the open market
  9. Aug 19, 2026Insider · 2 peopleInsiders: 2 sales (~$840K)

What came next

  1. Sep 2, 2026InsiderOfficer sold ~$98K of HIMS shares in the open market
  2. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$624K)
  3. Sep 16, 2026InsiderOfficer sold ~$174K of HIMS shares in the open market
  4. Sep 17, 2026InsiderCFO sold ~$355K of HIMS shares in the open market
  5. Sep 22, 2026InsiderCFO sold ~$877K of HIMS shares in the open market
  6. Sep 30, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
  7. Oct 1, 2026InsiderCFO sold ~$59K of HIMS shares in the open market
  8. Oct 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective October 9, 2026, concurrently with the previously disclosed resignation of Irene Becklund as the Company's principal accounting officer.”
  9. Oct 14, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
  10. Oct 28, 2026InsiderOfficer sold ~$96K of HIMS shares in the open market
  11. Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.0%
  12. Nov 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 4, 2026, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorship, effective immediately.”
  13. Nov 9, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  14. Nov 16, 20265% stakeG1 Execution Services, LLC reported a passive stake (13G) of 4.8%
  15. Nov 17, 2026Insider · 3 peopleInsiders: 3 sales (~$571K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Andrew Dudum, Chief Executive Officer

The full history of Andrew Dudum, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Hims & Hers Health (HIMS) insider traded, and how much?

Andrew Dudum, CEO at Hims & Hers Health, reported a gift / transfer of 463K shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Aug 25, 2026. Filed: Aug 28, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data